Markets of the Day
30 briefings archived

AI Earnings Fragility and Fed Expectations Anchor Cross-Asset Positioning as Macro Headwinds Ease


INTRODUCTION

Markets enter the week of November 9, 2026 navigating a tension between fading tail risks and mounting vulnerability in the AI earnings narrative that has powered equity gains. Asian stocks steadied as both geopolitical jitters in the Middle East and near-term AI-related anxiety receded, while the dollar held firm on expectations that the Federal Reserve will maintain a restrictive policy stance. Two catalysts dominate the week ahead: CoreWeave's earnings report and the forthcoming US inflation print, both of which carry outsized signaling power for the rate path and the sustainability of technology-sector valuations. Against this backdrop, Yardeni Research has warned that AI-related earnings expectations are reaching unsustainable levels, raising the bar for companies to deliver results that justify their multiples. Meanwhile, PGIM India's Aniruddha Naha argues that easing macro headwinds, reasonable valuations, and resilient corporate earnings have improved the risk-reward calculus for equities more broadly, offering a constructive counterpoint to the fragility thesis concentrated in AI.

FUTURE PROJECTIONS

BEST CASE:

CoreWeave delivers earnings that exceed expectations, reinforcing the AI capital-expenditure cycle and validating forward profit projections. The US inflation print comes in softer than consensus, prompting markets to reprice Fed rate cuts earlier, weakening the dollar and lifting risk assets across regions. In this scenario, the macro-cloud-lifting dynamic described by Naha is projected to broaden equity participation beyond AI into cyclical and emerging-market segments, supporting a durable rally.

BASE CASE:

CoreWeave posts results roughly in line with expectations, maintaining but not expanding the AI premium. Inflation data prints close to consensus, leaving the Fed's stance unchanged and the dollar steady at current levels. Equity markets trade sideways to modestly higher as the easing macro headwinds cited by Naha offset the valuation caution flagged by Yardeni Research. Volatility remains contained but concentrated around individual AI-linked names where the tolerance for disappointment is narrowing.

WORST CASE:

CoreWeave misses or guides cautiously, triggering a repricing across the AI complex as investors confront the unsustainable expectations Yardeni Research has identified. A hotter-than-expected inflation print reinforces the dollar's firmness on Fed hawkishness, tightening financial conditions. In this scenario, the convergence of earnings disappointment and rate repricing is projected to produce a sharp but likely short-lived risk-off episode, with particular pressure on high-multiple technology names and emerging-market currencies.

HISTORICAL CONTEXT

The current market configuration reflects the cumulative effect of several cycles. The AI investment theme has driven equity outperformance for multiple quarters, progressively raising the earnings bar that companies must clear. Yardeni Research's warning that these expectations are reaching unsustainable levels echoes prior episodes in which consensus forecasts outran delivery — most notably in prior technology-driven rallies where initial enthusiasm gave way to more discriminating positioning. Simultaneously, the Fed's policy trajectory has kept the dollar firm, a dynamic that has persisted long enough to become embedded in cross-asset positioning. The easing of Middle East geopolitical tensions and the broader macro stabilization referenced by Naha represent a potential inflection from the headwinds that weighed on risk appetite in prior months, particularly for Indian and broader Asian equities where valuations had compressed.

PRIMARY STAKEHOLDERS

The Federal Reserve remains the dominant macro actor; market expectations for a prolonged restrictive stance are underpinning dollar strength and shaping the rate-sensitive discount applied to growth equities. CoreWeave, as the AI infrastructure company reporting this week, serves as a bellwether for the durability of AI capital spending. Yardeni Research, in flagging the fragility of AI earnings expectations, speaks to institutional positioning concerns — asset managers running overweight AI risk face asymmetric downside if results disappoint. Aniruddha Naha of PGIM India represents the constructive institutional view on equities outside the US AI complex, arguing that macro stabilization and reasonable valuations create opportunity in segments where expectations are less stretched. Genmab held its 2026 revenue guidance of US$4.325 billion to US$4.525 billion and indicated performance is tracking toward the upper end, providing a pocket of earnings stability in healthcare even as its recent price action has been volatile.

ECONOMIC IMPLICATIONS

In equities, the week's outcome will determine whether AI-sector leadership can persist or must broaden. The inflation print directly impacts fixed-income pricing and, by extension, the dollar — a softer reading would relieve pressure on rate-sensitive assets, while a firm print would reinforce the dollar's current strength and compress emerging-market currencies. Volatility is likely to remain elevated around CoreWeave's report given the narrowing tolerance for AI misses. For Asian equities, the steadying tone reported by Reuters suggests that the immediate geopolitical risk premium has faded, leaving macro fundamentals and the Fed's rate path as the binding constraints on further upside.

Key Takeaways

Asian stocks steadied as AI-related anxiety and Middle East geopolitical jitters receded, while the dollar remained firm on expectations of sustained Fed restrictiveness.

CoreWeave earnings and the US inflation print are the two dominant catalysts for the week ahead, per CNBC.

Yardeni Research warned that AI earnings expectations are reaching unsustainable levels, reducing investor tolerance for disappointing results.

PGIM India's Aniruddha Naha identified easing macro headwinds, reasonable valuations, and resilient earnings as improving the equity risk-reward profile.

Genmab maintained 2026 revenue guidance of US$4.325 billion to US$4.525 billion, tracking toward the upper end, offering a stable earnings anchor in healthcare.

The dollar's firmness on Fed rate expectations remains a key cross-asset transmission mechanism affecting equities, fixed income, and emerging-market FX.

The convergence of stretched AI valuations and an imminent inflation catalyst creates asymmetric risk around high-multiple technology names.

AI equitiesUS dollarFederal Reserveinflation dataAsian equitiesearnings season

Source Articles